BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

424 related articles for article (PubMed ID: 17673563)

  • 41. Heat shock protein 70: A promising therapeutic target for myocardial ischemia-reperfusion injury.
    Song YJ; Zhong CB; Wang XB
    J Cell Physiol; 2019 Feb; 234(2):1190-1207. PubMed ID: 30132875
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Myocardial protection in reperfusion with postconditioning.
    Vinten-Johansen J; Zhao ZQ; Jiang R; Zatta AJ
    Expert Rev Cardiovasc Ther; 2005 Nov; 3(6):1035-45. PubMed ID: 16292995
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Mitochondrial pathways, permeability transition pore, and redox signaling in cardioprotection: therapeutic implications.
    Penna C; Perrelli MG; Pagliaro P
    Antioxid Redox Signal; 2013 Feb; 18(5):556-99. PubMed ID: 22668069
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Cardioprotection against reperfusion injury: updated mechanisms and strategies.
    Xi JK; Jin YZ; Cui X; Xu Z
    Sheng Li Xue Bao; 2007 Oct; 59(5):553-61. PubMed ID: 17940694
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Cardioprotective pathways during reperfusion: focus on redox signaling and other modalities of cell signaling.
    Pagliaro P; Moro F; Tullio F; Perrelli MG; Penna C
    Antioxid Redox Signal; 2011 Mar; 14(5):833-50. PubMed ID: 20649460
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Anesthetic cardioprotection in relation to mitochondria: basic science.
    Mio Y; Uezono S; Kitahata H
    Curr Pharm Des; 2014; 20(36):5673-80. PubMed ID: 24502577
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Reperfusion injury salvage kinase and survivor activating factor enhancement prosurvival signaling pathways in ischemic postconditioning: two sides of the same coin.
    Hausenloy DJ; Lecour S; Yellon DM
    Antioxid Redox Signal; 2011 Mar; 14(5):893-907. PubMed ID: 20615076
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Nuclear-encoded mitochondrial proteins and their role in cardioprotection.
    Boengler K; Heusch G; Schulz R
    Biochim Biophys Acta; 2011 Jul; 1813(7):1286-94. PubMed ID: 21255616
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Exercise-induced cardiac preconditioning: how exercise protects your achy-breaky heart.
    Frasier CR; Moore RL; Brown DA
    J Appl Physiol (1985); 2011 Sep; 111(3):905-15. PubMed ID: 21393468
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Cardioprotection of pharmacological postconditioning on myocardial ischemia/reperfusion injury.
    Wu Y; Liu H; Wang X
    Life Sci; 2021 Jan; 264():118628. PubMed ID: 33131670
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Long-term treatment with danshen-gegen decoction protects the myocardium against ischemia/reperfusion injury via the redox-sensitive protein kinase C-ε/mK(ATP) pathway in rats.
    Chiu PY; Wong SM; Leung HY; Leong PK; Chen N; Zhou L; Zuo Z; Lam PY; Ko KM
    Rejuvenation Res; 2011 Apr; 14(2):173-84. PubMed ID: 21204655
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Cardiac postconditioning.
    Pagliaro P; Penna C
    Antioxid Redox Signal; 2011 Mar; 14(5):777-9. PubMed ID: 20712411
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Ischemic postconditioning: from receptor to end-effector.
    Cohen MV; Downey JM
    Antioxid Redox Signal; 2011 Mar; 14(5):821-31. PubMed ID: 20518705
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Contribution of delayed intracellular pH recovery to ischemic postconditioning protection.
    Inserte J; Ruiz-Meana M; Rodríguez-Sinovas A; Barba I; Garcia-Dorado D
    Antioxid Redox Signal; 2011 Mar; 14(5):923-39. PubMed ID: 20578958
    [TBL] [Abstract][Full Text] [Related]  

  • 55. What makes the mitochondria a killer? Can we condition them to be less destructive?
    Murphy E; Steenbergen C
    Biochim Biophys Acta; 2011 Jul; 1813(7):1302-8. PubMed ID: 20837069
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Mitochondrial metabolism revisited: a route to cardioprotection.
    González-Loyola A; Barba I
    Cardiovasc Res; 2010 Nov; 88(2):209-10. PubMed ID: 20693164
    [No Abstract]   [Full Text] [Related]  

  • 57. Balance of nitric oxide and reactive oxygen species in myocardial reperfusion injury and protection.
    Folino A; Losano G; Rastaldo R
    J Cardiovasc Pharmacol; 2013 Dec; 62(6):567-75. PubMed ID: 23921313
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Myocardial postconditioning: anaesthetic considerations.
    Luna-Ortiz P; Torres JC; Pastelin G; Martínez-Rosas M
    Arch Cardiol Mex; 2011; 81(1):33-46. PubMed ID: 21592890
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The mitochondrial permeability transition pore as a target for preconditioning and postconditioning.
    Hausenloy DJ; Ong SB; Yellon DM
    Basic Res Cardiol; 2009 Mar; 104(2):189-202. PubMed ID: 19242644
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Protecting the heart from ischemia/reperfusion injury: an update on remote ischemic preconditioning and postconditioning.
    Donato M; Evelson P; Gelpi RJ
    Curr Opin Cardiol; 2017 Nov; 32(6):784-790. PubMed ID: 28902715
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 22.